Sarcopenia Treatment Market Share and Business Opportunities 2030
Sarcopenia Treatment Market: Strategic Insights
Sarcopenia Treatment Market
-
CAGR (2022 - 2030)5.6% -
Market Size 2022
US$ 3.4 Billion -
Market Size 2030
US$ 5.26 Billion
Market Dynamics
GROWTH DRIVERS
- Upsurge in Geriatric Population
- Rise in Malnutrition and Vitamin Deficiency Among Adults
FUTURE TRENDS
- Rising Awareness About Sarcopenia
OPPORTUNITIES
- Products in Clinical Trial Phases
Key Players
- Abbott Laboratories
- Bayer AG
- Metagenics LLC
- Nestle Health Science SA
- Novartis AG
- Pfizer Inc
- Sanofi SA
- Amway Corp
- GSK Plc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Treatment Type
- Vitamin D and Calcium Supplements
- Protein Supplements
- Vitamin B12 Supplements
Distribution Channel
- Pharmacies
- Retail Channels
- Online Channels